Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • LG 101506: Precision RXR Modulator for Nuclear Receptor S...

    2026-01-11

    LG 101506: Precision RXR Modulator for Nuclear Receptor Signaling Research

    Executive Summary: LG 101506 is a chemically defined, high-purity small molecule RXR modulator with a molecular weight of 420.53 g/mol and ≥98% purity (APExBIO, product page). It is soluble up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol under standard laboratory conditions. LG 101506 enables targeted modulation of the retinoid X receptor (RXR), facilitating detailed studies of nuclear receptor signaling pathways linked to metabolism and cancer immunity (Zhang et al., 2022). The compound is intended for research use only, not for diagnostic or therapeutic applications. Accurate storage at -20°C and prompt use of solutions maximize its stability and experimental reliability.

    Biological Rationale

    Retinoid X Receptor (RXR) is a nuclear receptor that forms heterodimers with other nuclear receptors, orchestrating gene transcription involved in metabolic regulation, cell differentiation, and immune modulation (Zhang et al., 2022). RXR signaling plays a pivotal role in cellular homeostasis, metabolic disease, and cancer biology, particularly in controlling immune checkpoint expression such as PD-L1. Recent studies implicate RXR in modulating tumor microenvironment immunogenicity, providing routes to enhance anti-tumor immune responses in immune-cold tumors like triple-negative breast cancer (TNBC). Targeting RXR can influence PD-L1 glycosylation and stability, potentially impacting the efficacy of immunotherapies (Zhang et al., 2022).

    Mechanism of Action of LG 101506

    LG 101506 acts as a small molecule modulator of RXR, with the chemical name (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid (APExBIO). Upon binding to RXR, LG 101506 alters the receptor conformation, affecting its interaction with DNA and co-regulators. This modulation influences transcriptional programs governing metabolism, immune surveillance, and cell fate. RXR activation or inhibition can downstream regulate immune checkpoint molecules (e.g., PD-L1) via transcriptional and post-translational mechanisms (Zhang et al., 2022). The compound's effect is dependent on experimental context, including cell type, RXR dimerization partner, and ligand concentration.

    Evidence & Benchmarks

    • LG 101506 demonstrates ≥98.00% purity (HPLC), ensuring minimal experimental confounders (APExBIO).
    • Solubility benchmarks: 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at 20–25°C (APExBIO).
    • RXR pathway modulation confirmed in published models of nuclear receptor signaling and metabolism regulation (see Zhang et al., 2022).
    • In immune-cold tumor research, RXR modulation can indirectly impact PD-L1 expression and glycosylation, affecting anti-tumor immunity (Zhang et al., 2022).
    • Standardized storage at -20°C maintains compound stability for up to 2 years unopened; solutions should be used promptly (APExBIO).
    • As shown in Chempaign.net, LG 101506 excels in models of nuclear receptor and metabolism research; this article extends prior findings by emphasizing applications in immune checkpoint biology and clarifying experimental caveats not covered in earlier summaries.

    Applications, Limits & Misconceptions

    LG 101506 is optimized for:

    • RXR signaling pathway research in cell lines and primary cells.
    • Modeling nuclear receptor-related disease mechanisms including metabolic disorders and cancer.
    • Dissecting immune checkpoint regulation in tumor microenvironments.
    • High-fidelity chemical biology experiments requiring a small molecule RXR ligand.

    Compared to prior reviews (e.g., Digoxigenin-11-UTP.com), this article details validated solubility and storage parameters, as well as up-to-date immunological applications, providing a clearer operational roadmap for researchers.

    Common Pitfalls or Misconceptions

    • LG 101506 is not approved for diagnostic or therapeutic use in humans or animals (APExBIO).
    • Long-term storage of solutions (>1 week) at room temperature or 4°C can result in compound degradation and experimental artifacts.
    • Solubility limits must be respected; exceeding 42.05 mg/ml in DMSO or 21.03 mg/ml in ethanol may cause precipitation.
    • The compound's effects are cell- and context-dependent; results may not generalize across all RXR-related disease models.
    • Interpretation of RXR modulation outcomes should consider dimerization partners (e.g., PPARs, LXR, FXR) and downstream pathways (GAP-27.com); this article clarifies these dependencies in relation to LG 101506's performance.

    Workflow Integration & Parameters

    For optimal results, LG 101506 from APExBIO (SKU: B7414) should be used as follows:

    • Reconstitution: Dissolve in DMSO (up to 42.05 mg/ml) or ethanol (up to 21.03 mg/ml) at 20–25°C. Vortex to ensure complete solubilization.
    • Aliquot and Storage: Store lyophilized powder at -20°C. Avoid repeated freeze-thaw cycles.
    • Preparation: Prepare working solutions immediately before use. Discard unused solutions after 24 hours.
    • Shipping: Product is shipped with blue ice (small molecule) or dry ice (modified nucleotides) to maintain stability.
    • Application: Use in in vitro RXR signaling assays, metabolic pathway dissection, or immune checkpoint studies under defined conditions.

    This article updates the integration protocol described by Phostag.net by specifying solubility, storage, and application caveats based on recent benchmarks and end-user feedback.

    Conclusion & Outlook

    LG 101506 is a rigorously benchmarked RXR modulator that empowers researchers to dissect nuclear receptor signaling with high specificity and reproducibility. Its chemical and biophysical properties facilitate advanced modeling of metabolism regulation and immune checkpoint control, particularly in models of cancer and metabolic disease. Ongoing research is expected to further elucidate the role of RXR and its modulators in immunotherapy and disease pathogenesis (Zhang et al., 2022). For detailed product specifications and ordering, see the LG 101506 product page at APExBIO.